期刊文献+

复方骨肽联合甘露醇治疗腰椎间盘突出症的疗效 被引量:1

Clinical observation of patients with lumbar disc disease treated by compound bone peptide combined with mannitol
下载PDF
导出
摘要 目的观察复方骨肽联合甘露醇治疗腰椎间盘突出症的临床疗效。方法将195例腰椎间盘突出症患者随机分为观察组A、观察组B及对照组,观察组A采用复方骨肽联合甘露醇治疗,观察组B采用甘露醇治疗,对照组仅给予对症治疗。治疗2周后,观察三组的临床疗效。结果三组患者在治疗2周后VAS评分均明显降低;与对照组比较,观察组VAS评分降低更明显;观察组A的VAS评分明显低于观察组B,差异具有统计学意义(P<0.05);观察组A的有效率明显高于观察组B,观察组A优良率明显高于对照组,差异具有统计学意义(P<0.05)。结论复方骨肽联合甘露醇治疗腰椎间盘突出症疗效显著,值得临床推广。 Objective To evaluate the efficacy of compound bone peptide combined with mannitol on patients with lumbar disc disease. Methods 195 patients with lumbar disc disease were randomly divided into observation group A, observation group B and control group, observation group A was treated by compound bone peptide combined with mannitol, observation group B was treated by mannitol, control group was given symptomatic treatment. To ob-serve the clinical efficacy of the three groups after treated for two weeks. Results The VAS scores of the three groups were significantly reduced after treated for two weeks. Compared with the control group, the VAS scores of the observa-tion group was more significantly reduced,the VAS scores of observation group A was significantly lower than of ob- servation group B ( P 〈 0. 05 ) ; the excellent rate of observation group A was significantly higher than that of the obser-vation group B, the excellent rate of observation group was significantly higher than that of the control group (P 〈 0. 05 ). Conclusion Compound bone peptide combined with mannitol is an effective treatment strategy formany pa-tients with lumbar disc disease, it is worthy to be popularized.
作者 李翊
出处 《实用药物与临床》 CAS 2013年第6期551-552,共2页 Practical Pharmacy and Clinical Remedies
关键词 复方骨肽 甘露醇 腰椎间盘突出症 Compound ossotide Mannitol Lumbar disc herniation
  • 相关文献

参考文献7

二级参考文献50

共引文献27

同被引文献12

引证文献1

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部